Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT01503658
Brief Summary:
This study has an open-label, five-period, single-sequence design. The purpose of this study is as follows;
1. Primary
* To evaluate the influence of genotype of drug metabolizing enzyme or transporter on the pharmacokinetics/pharmacodynamics of clopidogrel
* To evaluate the influence of aspirin on the pharmacokinetics/pharmacodynamics of clopidogrel
2. Secondary
* To explore the representative biomarkers for the variable pharmacokinetics/pharmacodynamics of clopidogrel
* To evaluate the influence of genotype of drug metabolizing enzyme or transporter on the drug-drug interactions between aspirin and clopidogrel
* To explore the representative biomarkers for the drug-drug interactions between aspirin and clopidogrel
Study:
NCT01503658
Study Brief:
Protocol Section:
NCT01503658